全国免费服务热线:021-64330607 服务时间 9:00-22:00 新浪微博 腾讯微博 注册 当前用户:[USERNAME],用户ID:[USERID] 用户中心 退出 收藏本页

archives of pharmacal research

来源:作者:热度:Loading...日期:2014-01-23, 07:46 PM

期刊名称 archives of pharmacal research 

期刊缩写 ARCH PHARM RES   
学科分类 医学、化学 

出版周期 双月刊   
审稿速度 3 个月 (平均) 

投稿命中率 50 % (均值)   
期刊主页 http://www.springer.com/biomed/pharmacology+%26+toxicology/journal/12272   
ISSN 号 0253-6269   
IF 趋势    2005     2006     2007     2008     2009     2010     2011     2012    
               0.818    0.929    1.085    1.074 1.159       1.588     1.592    1.538   
被收录情况  1. Science Citation Index Expanded 
                   2. Current Contents - Life Sciences 
                   3. BIOSIS Previews   
PubSci评语 韩国期刊,专注于药物发现、药物开发及药物作用和候选药物领域。版面费每页20美元。彩图额外计费。审稿速度慢,中稿率高。   
期刊简介 Archives of Pharmacal Research是一个致力于在药物发现、药物开发、药物作用及候选药物领域发表原创科研论文以及研究综述的多学科期刊。   
投稿注意事项 特别提醒:论文一旦确定接受后需要交纳每页20美元的版面费。默认是以黑白颜色发表,如果作者原意支付一定费用的话,可以彩图形式发表。
一般注意事项:
3. How to Submit Manuscripts
All submissions should be made online at the
Archives of Pharmacal Research Editorial Manager site at
www.editorialmanager.com/arpr. New users will fi rst
need to register. Once logged on to the site as an author,
follow the instructions to submit your manuscript.
Authors should submit the text, tables and artworks in
electronic form via this web-based manuscript submission
system.
Authors must include a cover letter that contains the title,
authors, a brief outline of the work’s originality, desired
section of publication, corresponding author’s name,
address, telephone and fax numbers (including country and
city codes), and e-mail address.
4. Review of Manuscripts
All manuscripts are first evaluated for their scientific
content and significance by the editors and will be
subjected to at least two independent reviewers.
However, editors reserve the right to reject a manuscript
without conducting an in-depth review if they feel
that the manuscript is out of the scope or does not
meet the minimal acceptance criteria for publication.
The manuscript with incorrect format may be declined
without further review.
5. Proofs
Authors are basically responsible for the factual accuracy
of their papers. One set of proofs will be supplied for
the author to check for typesetting accuracy, to be
returned to the publisher within 3 days of receipt.
No changes to the original manuscript will be allowed
at this stage. In addition, the editors reserve the right to
make any necessary correction to a paper prior to
publication.
6. Transfer of Copyright
All authors must sign the ‘Transfer of Copyright’
agreement before the article can be published. This transfer
agreement enables the Pharmaceutical Society of Korea to
protect the copyrighted material for the authors, but does
not relinquish the author’s proprietary rights.
7. Publication Charges
The Archives of Pharmacal Research charges a publication
fee of US $20 per printed page upon the acceptance of the
manuscript on the form accompanying the proofs.
8. Reprints
Fifty reprints of each accepted paper will be supplied
to the corresponding author at no cost. Additional
reprints will be available by ordering on the reprint order
form.
1. Aims and Scope
Archives of Pharmacal Research is an interdisciplinary
journal devoted to the publication of original scientifi c
research papers and reviews in the fi elds of drug discovery,
drug development, and drug actions with a view to
providing fundamental and novel information on drugs and
drug candidates.
Manuscripts will be considered for publication on the
condition that the results reported are based on original
research that has not been published elsewhere in any
journal.
Upon acceptance for publication of an article in Archives
of Pharmacal Research, the author tacitly agrees to make
available any materials used in the published experiments,
or novel or natural products disclosed in the article that are
not commercially available, so that other researchers may
confi rm the observations.
For the studies using natural extract, the journal will
determine the acceptability of such papers on an individual
basis. Natural product contribution must meet the following
specifi c criteria: a) any natural extract must be defi ned, and
appropriate information provided regarding the origin;
b) the author must be able to state that the material under
study is endotoxin free.
2. Types of Papers
Archives of Pharmacal Research considers manuscripts for
publication in the following types of papers:
Research Articles. These are full-length descriptions of
research that describe original and important pieces of work
in detail from the fi elds covered by the journal. Maximum
length of manuscripts should not exceed 6,000 words (24
typescript pages) excluding fi gures and tables. At least,
4 fi gures or tables (in total) should be included. These
manuscripts will undergo standard review and normally are
not expedited.
Reviews. Invited or author-initiated review articles within
the scope of Archives of Pharmacal Research will be considered
for publication. Authors may submit a short synopsis to
editors (pskor@korea.com) regarding content and length
prior to submission. At least, 3 fi gures or tables (in total)
should be included (for Review). Please note that reviews
will be subjected to appropriate evaluation process.
Report on Investigational Drugs. We have created a new
section called ‘Report on Investigational Drugs’, to cover recent
updates in the fi eld of drug development and discovery. The
report should describe recent trends in new drug development
among pharmaceutical and bio-venture companies, research
institutes and universities. A focused report on one particular
drug would be recommended. The report should contain a
brief background, a description of drug candidate (e.g., effects
and relevant experimental data) and its prospective view. The
total length should be about 1000 words excluding references.
Instruction for Authors
the research and publication ethics not stated, ‘Good
Publication Practice Guidelines for Medical Journals
(http://kamje.or.kr/publishing_ethics.html)’ or ‘Guidelines
on good publication (http://www.publicationethics.org. uk/
guidelines)’ can be applied.
Results. In this section, only observations should be
described without discussion of their signifi cance.
Discussion. The authors’ interpretations of their observations
(or fi ndings) should be accompanied by an assessment of their
signifi cance in relation to previous work.
Confl ict of Interest All authors are requested to disclose
any actual or potential confl ict of interest including any
fi nancial, personal or other relationships with other people
or organizations within three years of beginning the
submitted work that could inappropriately infl uence, or be
perceived to infl uence, their work.
Acknowledgements. The Acknowledgment section should
include credits [initial(s) and last name] for technical assistance,
fi nancial support, and other appropriate recognition.
References. EndNote is a software product that we
recommend to our journal authors to help simplify
and streamline the research process. Using EndNote’s
bibliographic management tools, you can search bibliographic
databases, build and organize your reference collection,
and then instantly output your bibliography in any journal
style.
Download Reference Style for this Journal: If you
already use EndNote, you can download the Endnote
output style fi le (Arch Pharma Res.ens).
Only papers closely related to the author’s work should be
cited. References should be assembled alphabetically. In the
text, they should be referred by name and year (Harvard
system). When referring to more than one paper from a
same author from a same year, the alphabets a, b, c, etc. should
be placed next to the year of publication to distinguish the
articles. In the text, when referring to a work by sole author,
the name of author should be given like (Robinson, 1998)
and (Robinson, 1999; Jeong, 2000). When referring to a work
by two authors, the name of authors should be given like
(Robinson and Jeong, 2001). When referring to a work by
more than three authors, the name of the fi rst author should
be given followed by et al. such as (Robinson et al., 2002).
Literature references must consist of names and initials
of all authors, title of the paper referred to, abbreviated
title of the journal and the volume, year, and fi rst and last
page numbers of the paper. The style and punctuation
of the references should confi rm with the following
examples:
Journals:
Lai, Y.-L., Mehta, R.C., Thacker, A.A., Yoo, S.-D., MacNamara,
P.J., and DeLuca, P.P., Sustained bronchodilation with
isoproterenol poly(glycolidecolactide) microspheres. Arch.
Pharm. Res., 10, 119–125 (1993).
9. Preparation of Manuscripts
Manuscripts should be concisely written in English
and typed double-spaced throughout on A-4 paper with
margins of at least 3.0 cm. All pages should be numbered in
succession, the title page being page 1.
Title Page. Each manuscript must have a title page,
which includes only the title, the authors’ names with their
affi liation, a running title of not more than 50 characters
including spaces, and mailing address, which includes
telephone and fax numbers and e-mail address of the
corresponding author. Place an asterisk after the name of the
corresponding author. Author affi liations must be footnoted
using superscript numbers. The title should be a brief phrase,
not a complete sentence, describing the contents of the
manuscript. Symbols, formulas, or arbitrary abbreviations
should not be included in the title, except chemical symbols
to indicate the structure of isotopically labeled compounds.
Abbreviation. The excessive use of abbreviations in
the text is strongly discouraged. Authors should only
use abbreviations sparingly and should always defi ne an
abbreviation when fi rst used by placing it in parentheses
after the full term, e.g. Acetylcholinesterase (AChE). The
metric system for all measurements should be expressed in
lowercase letters without periods (ml, nm, min, etc.).
Drug Names. Drug names should be the offi cial or
approved names; trade names or common names may be
given in brackets where the drug is fi rst mentioned. The
name of the manufacturer, not the address, should be given.
The doses of the drugs should be given as unit weight/unit
body weight, e.g. mmol/kg or mg/kg. Concentration should
be given in terms of molarity (e.g., nM or mM), or as unit
weight/unit volume solution (e.g., mg/ l) stating whether the
weight refers to the salt or the active component of the drug.
10. Organization of Manuscripts
Each manuscript must begin with an ABSTRACT that
summarizes the results obtained and the conclusion drawn.
It should not exceed 200 words. A short list of six keywords
or phrases should be supplied following the abstract.
Introduction. An introduction should fi rst begin with
general aspect for a non-specialist and then continue with
the specifi c reason for undertaking the investigation. No
attempt should be made to indicate the results obtained.
Materials and Methods. Procedures used in the work
should be given in suffi cient detail to permit the repetition
by other researchers. Nevertheless, published procedures
should be briefl y summarized by mentioning the reference(s)
and only described in detail if the procedures have been
modifi ed. The name of manufacturer should be specifi ed
without address (e.g., city and country).
[Ethics] All human and animal studies must have been
approved by the author’s institutional review board and
the name of the review board should be stated. All clinical
investigation must have been conducted according to
Declaration of Helsinki principles. For the policies on
4) Legends: All legends should be typed consecutively
in a separate section of the manuscript. Each legend
must give a concise description of the fi gure and scheme
concerned, together with any essential experimental details
not described in the text. In particular, the key to any
symbols or distinctive line formats used on the fi gure must
be given.
5) Contents: Abbreviations such as Me for CH3, Et for
C2H5, and Ph (but not j) for C6H5 are acceptable. Make
liberal use of “R and X groups” in equations, schemes, and
structure blocks to avoid the repetition of similar structures.
Do not repeat a structure; the number alone of an earlier
structure can be used if a compound occurs several times.
Schemes are numbered with Arabic numerals. Within
schemes, structures should be numbered with boldface
Arabic numerals, consecutively from left to right, top to
bottom, regardless of the order in which the compounds
are discussed in the text. Schemes should be footnoted in
the manner described below for Tables. It is not necessary
to give reagents and conditions in complete detail, since
this detail is contained in the Experimental Section. Where
needed, numbers such as NMR chemical shifts may be
included directly on structural formulas.
Chemical Structures. Drawing preferences (preset in the
ACS Stylesheet in ChemDraw) are as follows:
1. As drawing settings select:
chain angle 120º
bond spacing 18% of width
fi xed length 14.4 pt (0.508 cm, 0.2 in.)
bold width 2.0 pt (0.071 cm, 0.0278 in.)
line width 0.6 pt (0.021 cm, 0.0084 in.)
margin width 1.6 pt (0.056 cm, 0.0222 in.)
hash spacing 2.5 pt (0.088 cm, 0.0347 in.)
2. As text settings select:
font Arial/Helvetica
size 10 pt
3. Under the preferences choose:
units points
tolerances 5 pixels
4. Under page setup choose:
paper US Letter
scale 100%
5. Using the ChemDraw ruler or appropriate margin
settings, create structure blocks, schemes, and equations
having maximum widths of 11.3 cm (onecolumn format)
or 23.6 cm (two-column format). Note: if the foregoing
preferences are selected as cm values, the ChemDraw
ruler is calibrated in cm. ChemDraw graphics will be
reduced to 75% during production.
6. Embolden compound numbers, but not atom labels or
captions.
Books:
Azria, M., The Calctionins: Physiology and Pharmacology.
Karger, London, (1989).
Borchartdt, R. T., Hidalgo, I. J., Hillgren, K. M. and Hu., M.,
Pharmaceutical applications of cell culture: An Overview, In
Wilson, G., Davis, S.S., Illum, L. and Zweibaum, A. (Eds.).
Pharmaceutical Application of Cell and Tissue Culture to Drug
Transport. Plenum Press, New York, pp. 1–14, (1991).
Journal names should be abbreviated in accordance with
Chemical Abstracts or Biological Abstracts List of Serials.
Experimental Data. If possible, statistical signifi cance
of the experimental data should be provided. Statistical
probability (p) in tables, fi gures, fi gure legends and text
should be expressed as *p < 0.05, **p < 0.01, and ***p < 0.001.
For multiple comparisons within a table, footnotes italicized
in lower case, superscript letters should be used and defi ned
in the table legend. References to statistical methods of
calculation should be provided. If statistical limits cannot
be provided, the number of determinations and some
indication of the variability and reliability of the results
should be provided. For animal experimental data, doses
and concentrations should be expressed as molar quantities
(e.g., mmol/kg, mM) when comparisons are made between
compounds having large differences in molecular weights.
The routes of administration of test compounds and vehicles
used should be indicated.
Figures. All fi gures (drawings, schemes, charts and
photographs) should be numbered in one consecutive series
of Arabic numerals in the order cited in the text.
1) Graphics: To ensure the highest print quality, your
fi gures must be submitted in either TIF or EPS format
according to the following minimum resolutions:
Black and white line art 1200 dpi
Grayscale art 600 dpi
Color art 300 dpi
2) Colors: Remove all color from graphics, except for
those graphics that you would like to have considered for
publication in color. Color photographs will be printed at
the Editors discretion, on the understanding that the authors
will bear the cost.
3) Layout: Figures should be submitted in the actual size
at which they should appear in the Journal. They may be
printed in either single column (80 mm width) or double
column (165 mm width) format. The single column format
is preferred. The size of text in fi gures should be 8-10 points,
except for single letter markers which may be 12 points. The
use of sans serif font such as Helvetica is preferred. Numbers,
letters, and symbols used in multi-paneled fi gures must be
consistent. Complex textures and shading to achieve a threedimensional
effect should be avoided. To show a pattern,
a simple cross-hatch design should be used. Lines should
be no thinner than 0.5 point. For a line graph, use standard
symbols in the following order of preference: ○, ●, □, ■, D,
▲; x and + should be avoided.
Tables. These should be numbered consecutively with
Roman numerals in the order cited in the text. Tables should
be formatted with horizontal lines only: vertical ruled
lines are not required. Footnotes in tables should be given
lowercase letter designations and be cited in the table by
italic superscript letters. Each table should be provided with
a descriptive heading, which, together with the individual
column headings, should make the table, as nearly as
possible, self-explanatory. In setting up tabulations, tables
need to fi t the type area of the journal page (17.8 × 25.4 cm)
and the column width (8.5 cm). Arrangements that leave
many columns partially fi lled or that contain much blank
space should be avoided.
7. Authors are urged to use only a single confi gurational
descriptor (heavy line or dashed line, but not both) when
defi ning a stereocenter in a chemical structure. Atoms
should be kept outside of rings wherever possible. Rather
than rectangular solid and dashed lines, authors should
use solid and dashed wedges to indicate confi gurations, as
shown below. Dots at ring junctions intended to represent
hydrogen atoms should not be used. Structures should be
drawn in a neat manner ready for direct reproduction,
and should not be cluttered or overlapping. Any arrows
and numbering used for atoms in fi gures should not
come into contact with bonds or ring systems. See an
example of a prepared structure using ChemDraw with
the specifi ed preferences below. In molecules containing
a chiral biphenyl axis, it is recommended that one of the
aromatic rings be drawn in the plane of the paper and the
second one be rotated out of the plane of the paper, to
refl ect the P or M conformation about the biphenyl bond
(see below for example).
http://www.springer.com/journal/12272
   
编辑部信息 所在地: 首尔 国家 韩国   
  EDITOR-IN-CHIEF
Aree Moon
Duksung Women's University
Tel: +82-2-901-8394
Email: armoon@duksung.ac.kr  


EDITORS
Hyo-Kyung Han
Dongguk University
Tel: +82-31-961-5217
Email: hkhan@dongguk.edu 

Eun Sook Hwang
Ewha Womans University
Tel: +82-2-3277-4369
Email: eshwang@ewha.ac.kr  

Chang Hoon Lee
Dongguk University
Tel: +82-2-2260-8905
Email: uatheone@gmail.com  

Joo Young Lee 
The Catholic University of Korea
Tel: +82-2-2164-4095
Email: joolee@catholic.ac.kr 

Eun-Kyoung Seo
Ewha Womans University
Tel: +82-2-3277-3047
Email: yuny@ewha.ac.kr   


ASSOCIATE EDITORS
Youngjoo Byun (Korea University, Korea)
Young-Won Chin (Dongguk University, Korea)
Hyosun Cho (Duksung Women's University, Korea)
Won-Jea Cho (Chonnam National University, Korea)
Sang-Bae Han (Chungbuk National University, Korea)
Jongki Hong (Kyung Hee University, Korea)
Tae Cheon Jeong (Yeungnam University, Korea)
Keon Wook Kang (Seoul National University, Korea)
Donghak Kim (Konkuk University, Korea)
Hyun-Jung Kim (Chung-Ang University, Korea)
Kyeong-Man Kim (Chonnam University, Korea)
Sang Kyum Kim (Chungnam National University, Korea)
Seung Hyun Kim (Yonsei University, Korea)
So Ra Kim (Seoul National University of Science and Technology, Korea)
Yoon Gyoon Kim (Dankook University, Korea)
Mi-Kyoung Kwak (The Catholic University of Korea, Korea)
Hwa Jeong Lee (Ewha Womans University, Korea)
Hyukjin Lee (Ewha Womans University, Korea)
Hyun-Tai Lee (Dong-Eui University, Korea)
Jeeyeon Lee (Seoul National University, Korea)
Mi Kyeong Lee (Chungbuk National University, Korea)
Mi-Kyung Lee (Woosuk University, Korea)
Sukhyang Lee (Ajou University, Korea)
Dong Hee Na (Kyungpook National University, Korea)
MinKyun Na (Chungnam National University, Korea)
Younghwa Na (CHA University, Korea)
Jung Mi Oh (Seoul National University, Korea)
Myung Sook Oh (Kyung Hee University, Korea)
Sunghyouk Park (Seoul National University, Korea)
Youmie Park (Inje University, Korea)
Jong Hoon Ryu (Kyung Hee University, Korea)
Jae Hong Seo (The Catholic University of Korea, Korea)
Mi-Ryoung Song (Gwangju Institute of Science and Technology, Korea)
Yu Seok Youn (SungKyunKwan University, Korea) 

网友投稿经验整理:
这个杂志太慢了,我投稿一周没有人处理,写信给编辑部也没有人理,然后给springer负责人写信,他帮我催了一下,才分了一个editor,然后又没有消息了,真是晕,不知道他们的人都在做什么呢
贡献者: 114.103.40.211
审稿时间:约3个月    接收率:约50%     
with editor 的状态就持续了1个月,under review 就久了,起码3个月,
好不容易有了修回的意见,返回给杂志社以后,又等了快3个月,催了两次没有音信,最后实在是等不了了,给主编发了邮件说准备撤稿,才回复我说文章被接受了。然后3个月后,拿到了语言润色后的修改版本,要求你确认一下有没有被改错的地方,但是清样什么时候能拿到,还暂时未知。
贡献者:catherine21dan
研究方向:药理学 中医学              
这个杂志就是慢,但是容易中,08年的时候还要纸质版,和硬盘邮寄,很麻烦
贡献者:longqiaoqian
我去年7月投稿的,8月末让修改,我10月4日修回的,12日接受的,到今年的6月开始校稿,校了三次,没音信了。无意中发现竟然已经发表了,我自己还没有正式的全文,我问杂志社,怎么不给我全文呢,没回。后来我找到PDF版本自己下载的。
贡献者:222.170.105.135
发稿时间太慢,如果想快速发表,千万别找它,ACCEPT后整整1年半才发稿。
贡献者:61.178.220.135

扫描二维码
关注Pubsci微信
微信公共账号:pubsci888

关键词:论文翻译润色,论文评估,SCI投稿,SCI期刊发表,医生出国进修